Finance
Markets

PFE

stock NYSE
Pfizer Inc.
$25.95 +0.16 (+0.62%) At close

Key stats

The day open and close within the day's range
Low $25.57 High $25.96
Open
$25.77
-0.10%
Close
$25.95
+0.62%
52-week range where the price sits across its year
52w low $22.81 52w high $28.75
Current
$25.95
Prev close
$25.79
Volume 0.54× the 3-month average
0 avg 2× avg
Today
20.18M
3-mo avg
37.70M

Fundamentals

Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.

P/E ratio Strong
19.1x

At 19x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
6.63%

A 6.6% yield is high; it is worth checking the payout is covered by profit.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
12.4%

A 12.4% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
9.0%

A 9.0% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.7%

A 3.7% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.40

At 1.40, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.16

At 1.16, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Weak
-1.6%

Revenue fell 1.6% from the prior year; the top line is contracting.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-3.2%

Net income fell 3.2% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financials

FY2021FY2022FY2023FY2024FY2025
Revenue $73.6B$101.2B$59.6B$63.6B$62.6B
Net income $22.0B$31.4B$2.1B$8.0B$7.8B
Diluted EPS $3.85$5.47$0.37$1.41$1.36
Dividend / share $1.57$1.61$1.65$1.69$1.72
Total assets $181.5B$197.2B$226.5B$213.4B$208.2B
Total liabilities $104.0B$101.3B$137.2B$124.9B$121.4B
Shareholder equity $77.5B$95.9B$89.3B$88.2B$86.5B

Recent SEC filings